Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Saliva Test to Enable Early Detection of Diabetes and Obesity

By LabMedica International staff writers
Posted on 04 Aug 2025

Type 2 diabetes affects about 400 million people globally and is typically diagnosed through elevated blood glucose levels. More...

However, conditions like insulin resistance and hyperinsulinemia may begin developing 10 to 20 years before a diagnosis. Detecting hyperinsulinemia early is important because it is a known predictor of several chronic conditions, including Type 2 diabetes, hypertension, cardiovascular disease, stroke, cancer, and obesity. Current methods to detect insulin levels require invasive blood sampling and lab-based analysis, making early detection less accessible. Now, a new study reveals that a saliva-based test may offer a simple, non-invasive method to identify people at risk of developing metabolic disorders, even before symptoms appear or blood sugar levels begin to rise.

The study, by researchers at the UBC Okanagan’s School of Health and Exercise Sciences (Kelowna, BC, Canada), evaluated whether insulin levels in saliva could serve as a reliable indicator of metabolic health. The research included 94 healthy participants across a range of body sizes who, after a fasting period, consumed a standardized meal-replacement shake. Saliva samples were collected at 30, 60, and 90 minutes post-consumption, alongside finger-prick blood glucose tests. Prior studies at UBCO had already shown that saliva insulin levels closely track plasma insulin levels throughout the day, even after meals with differing carbohydrate contents. This new study aimed to build on that insight and develop a practical, needle-free test for early detection of hyperinsulinemia.

The findings, published in Applied Physiology, Nutrition, and Metabolism, indicate that saliva insulin levels were significantly higher in individuals with obesity, even when their blood glucose levels remained normal. The study also discovered that some lean individuals exhibited large saliva insulin spikes after the test meal, suggesting elevated risk despite healthy weight and glucose levels. Additionally, waist circumference showed a stronger correlation with elevated saliva insulin than age or overall body weight, indicating it may be a better predictor of early metabolic dysfunction. Researchers suggest that saliva testing could become a valuable tool to distinguish between metabolically healthy individuals and those at risk, and future work will focus on refining this method for broader clinical application.

"If hyperinsulinemia can be detected before blood glucose levels start to rise, people at risk for Type 2 diabetes could be identified early, allowing for lifestyle changes and other treatments to be introduced long before glucose levels rise," said Dr. Jonathan Little, lead investigator of the study.

Related Links:
UBCO School of Health and Exercise Sciences


Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Sample Transportation System
Tempus1800 Necto
Laboratory Software
ArtelWare
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Noul’s AI-based cervical cancer diagnostic solution, miLab CER (Photo courtesy of Noul)

AI-Powered Cervical Cancer Test Set for Major Rollout in Latin America

Noul Co., a Korean company specializing in AI-based blood and cancer diagnostics, announced it will supply its intelligence (AI)-based miLab CER cervical cancer diagnostic solution to Mexico under a multi‑year... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.